Crescita Therapeutics Inc. (CTX.TO)
Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
As of 11:20AM EDT. Market open.
Currency in CAD
Valuation Measures4
| Market Cap (intraday) | 8.40M |
| Enterprise Value | 271.80k |
| Trailing P/E | 23.67 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.50 |
| Price/Book (mrq) | 0.45 |
| Enterprise Value/Revenue | 0.02 |
| Enterprise Value/EBITDA | 4.46 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change 3 | -33.85% |
| S&P500 52-Week Change 3 | 26.36% |
| 52 Week High 3 | 0.7300 |
| 52 Week Low 3 | 0.3600 |
| 50-Day Moving Average 3 | 0.4225 |
| 200-Day Moving Average 3 | 0.5147 |
Share Statistics
| Avg Vol (3 month) 3 | 12.14k |
| Avg Vol (10 day) 3 | 6.8k |
| Shares Outstanding 5 | 19.54M |
| Implied Shares Outstanding 6 | 20M |
| Float 8 | 17.2M |
| % Held by Insiders 1 | 10.71% |
| % Held by Institutions 1 | 0.00% |
| Shares Short (Apr 30, 2024) 4 | 1.72k |
| Short Ratio (Apr 30, 2024) 4 | 0.01 |
| Short % of Float (Apr 30, 2024) 4 | N/A |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.01% |
| Shares Short (prior month Mar 28, 2024) 4 | 3.74k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -13.05% |
| Operating Margin (ttm) | -14.63% |
Management Effectiveness
| Return on Assets (ttm) | -5.90% |
| Return on Equity (ttm) | -12.00% |
Income Statement
| Revenue (ttm) | 17.92M |
| Revenue Per Share (ttm) | 0.89 |
| Quarterly Revenue Growth (yoy) | 8.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1.34M |
| Net Income Avi to Common (ttm) | -2.34M |
| Diluted EPS (ttm) | -0.1000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.53M |
| Total Cash Per Share (mrq) | 0.49 |
| Total Debt (mrq) | 1.15M |
| Total Debt/Equity (mrq) | 6.32% |
| Current Ratio (mrq) | 3.59 |
| Book Value Per Share (mrq) | 0.93 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 323k |
| Levered Free Cash Flow (ttm) | 502.12k |
© 2024 Yahoo. All rights reserved.